People · Operator
Named in public records as an officer, director or promoter · active 2015–2022 · Biotechnology, Investment Vehicle, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Delfi Diagnostics, Inc. | — | Biotechnology | Series D+ | $365.9M | $235.7M | 2022 |
| Helix Holdings I, LLC | — | Investment Vehicle | Series D+ | $235.0M | $764.9M | 2015 |
| Inflammatix, Inc. | — | Biotechnology | Series D+ | $134.5M | $3.3B | 2021 |
| Earli Inc. | — | Other Health Care | Series B | $40.0M | $756.4M | 2021 |
Justin Kao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Justin Kao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rishi Gupta | 1 | 12 |
| Noah Knauf | 1 | 9 |
| Greg Yap | 1 | 8 |
| Michael Rubin | 1 | 8 |
| JEFF BIRD | 1 | 7 |
| Jeffrey W. Bird | 1 | 6 |
| Jeffrey Bird | 1 | 5 |
| MICHAEL DYBBS | 1 | 5 |
| Jorge Conde | 1 | 4 |
| William Stevens | 1 | 3 |
| Jay Flatley | 1 | 3 |
| James Lu | 1 | 3 |
| Barry M. Schuler | 1 | 3 |
| Steven Tablak | 1 | 2 |
| Victor Velculescu | 1 | 2 |
| Amr M. Kronfol | 1 | 2 |
| Peter Bach | 1 | 2 |
| Elizabeth Homans | 1 | 2 |
| TIMOTHY SWEENEY | 1 | 2 |
| Cyriac Roeding | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.